Compare Wegovy vs Mounjaro: UK Stock Available Now
Wegovy or Mounjaro for Weight Loss: UK Availability Advantage
The biggest concern when choosing between Wegovy or Mounjaro for weight loss isn't just effectiveness—it's whether you can actually access your chosen treatment when you need it. EverydayMeds addresses this directly by maintaining comprehensive stock of both medications through our established UK supply chains. All five Wegovy doses (0.25mg through 2.4mg) are available for immediate dispatch, while Mounjaro stock levels remain consistently reliable for new patient starts. This dual availability means your treatment choice can be based purely on clinical suitability rather than supply constraints.
Our GPhC-registered pharmacy (#9012878) has invested significantly in cold-chain infrastructure and supplier relationships to eliminate the treatment delays that have historically affected weight management medication access. When comparing Wegovy or Mounjaro for weight loss, you can make your decision knowing both options ship within 24 hours of prescriber approval. This reliability extends beyond initial treatment—maintenance doses remain consistently available, supporting long-term treatment continuity that's essential for sustained weight management outcomes.
Pricing Comparison: Wegovy or Mounjaro for Weight Loss Costs
Understanding the financial commitment when choosing between Wegovy or Mounjaro for weight loss requires transparent pricing information. Wegovy starts at £79.99 for the 0.25mg starter dose (after FIRST40 discount for new customers), progressing to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient multi-month supplies: the Intro Duo (0.25mg and 0.5mg) costs £169.99, while the Ultimate Stability Trio offers three months of 2.4mg maintenance for £649.99. Mounjaro pricing follows a different structure, with returning customers benefiting from the DOSE25 code at checkout.
The cost-effectiveness equation extends beyond initial pricing when evaluating Wegovy or Mounjaro for weight loss options. Wegovy's storage advantage—remaining stable at room temperature for 6 weeks versus Mounjaro's 21 days—can reduce wastage if travel or routine disruptions occur. Bundle purchasing eliminates multiple ordering fees and ensures treatment continuity, particularly valuable during dose escalation phases where timing is crucial. Both medications qualify for our express prescriber review service (24-hour turnaround) at no additional cost, adding value to your treatment investment.
Clinical Evidence: Wegovy or Mounjaro for Weight Loss Efficacy
The clinical foundation supporting both options in the Wegovy or Mounjaro for weight loss decision involves different trial populations and endpoints, making direct comparison challenging. Wegovy's evidence base centres on the STEP trial programme, where participants achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, adding health benefits beyond weight management.
Mounjaro's clinical profile stems from its dual-receptor mechanism targeting both GIP and GLP-1 pathways, though these trials involved different methodologies and patient populations. Both medications require prescription-only access and clinical assessment to ensure appropriate patient selection. Your EverydayMeds prescriber can evaluate which evidence base aligns better with your individual health profile, medical history, and weight management goals when determining the optimal choice between Wegovy or Mounjaro for weight loss.
How Wegovy Works in Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones to regulate appetite and food intake. The medication works primarily through the hypothalamus—your brain's appetite control centre—to reduce hunger signals and enhance satiety after smaller meals. This neurological approach means you may naturally feel satisfied with less food rather than relying on willpower alone to reduce portion sizes. The once-weekly injection via FlexTouch pen provides consistent medication levels, avoiding the peaks and valleys associated with daily treatments. Clinical studies suggest Wegovy may also reduce food cravings and the psychological drive to eat, addressing both physiological and behavioural aspects of weight management when used alongside a reduced-calorie diet and increased physical activity.
Streamlined Ordering Process for Both Medications
Accessing either option in your Wegovy or Mounjaro for weight loss decision requires the same straightforward process through EverydayMeds. The clinical assessment takes approximately three minutes, covering medical history, current medications, weight management goals, and lifestyle factors that influence treatment selection. Our prescribers typically complete reviews within three working days (24 hours with express service), ensuring thorough evaluation while minimising delays. Once approved, both medications ship via next-day cold-chain delivery, maintaining the 2-8°C storage requirements throughout transit. The entire process from assessment submission to treatment delivery typically completes within 4-5 days, allowing you to begin your chosen weight management programme quickly and safely.
Storage and Practical Considerations
Practical differences between options can influence your Wegovy or Mounjaro for weight loss selection, particularly around storage and handling requirements. Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks of room temperature stability (below 30°C) once removed from the fridge. Mounjaro maintains stability for 21 days at room temperature, which may suit most lifestyle needs but could be limiting for extended travel or irregular schedules. The FlexTouch pen system for Wegovy provides consistent, user-friendly injection experience with clear dose confirmation. Dose escalation protocols differ between medications, with Wegovy following a structured 16-week progression to maintenance dosing. Both treatments require consistent weekly injection timing to maintain stable therapeutic levels and minimise potential side effects.
UK Supply Chain Reliability for Long-term Treatment
The sustainability aspect of choosing between Wegovy or Mounjaro for weight loss extends beyond initial availability to long-term supply security. EverydayMeds has established direct relationships with both Novo Nordisk (Wegovy manufacturer) and Eli Lilly (Mounjaro manufacturer) to ensure consistent UK stock levels. Our inventory management systems monitor usage patterns and seasonal fluctuations to prevent supply gaps that could disrupt your treatment continuity. This infrastructure investment means your medication choice can focus on clinical suitability rather than availability concerns.
Weight management represents a long-term commitment, and medication interruptions can significantly impact outcomes. Our automated prescription renewal system tracks your dosing schedule and proactively manages refills before you run low. Both Wegovy and Mounjaro qualify for our subscription service, ensuring your chosen treatment arrives consistently without repeated ordering processes. This reliability proves particularly valuable during maintenance phases where consistent dosing supports sustained weight management results.
Expert Guidance: Making Your Treatment Decision
The final element in your Wegovy or Mounjaro for weight loss evaluation involves expert clinical guidance tailored to your specific circumstances. Our prescribers consider factors including your medical history, concurrent medications, lifestyle requirements, and personal preferences when recommending between treatment options. Both medications are available from EverydayMeds, and your prescriber can help determine which aligns better with your individual needs and goals. The clinical assessment process evaluates your BMI, weight-related health conditions, previous weight management attempts, and realistic treatment expectations to guide optimal selection. Whether you proceed with Wegovy's proven GLP-1 approach or Mounjaro's dual-receptor mechanism, our team provides ongoing support throughout your weight management journey. Access both options through our secure platform at https://everydaymeds.co.uk/collections/wegovy, where new customers can apply code FIRST40 and returning customers can use DOSE25 for discounted pricing at checkout.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
